Capital Network Equity Research & Stock Reports
- Professional research and all the latest forecasts, valuation opinions and multiples from Capital Network's expert analysts.
- Real-time updates from analysts following company announcements and other events.
- Near-live share prices, user-friendly dashboard, charting and company content.
Thor Mining - Poised for Development
Thor Mining is an exploration and development company with an advanced tungsten/molybdenum project poised for development; and exciting lithium and tungsten exploration projects. Thor is listed on the Alternative Investment Market (AIM) in London and the Australian Stock Exchange (ASX).
26 Jun 17
Greatland Gold has a suite of exploration assets in Australia
Agreement with a global major: Global major gold miner, Newmont, has recently entered into an agreement with Greatland such that Newmont will have access to Greatland’s Ernest Giles gold project for a period of 6 months, and is able to apply their proprietary exploration methods (which, we understand, are ideally suited for identifying large gold systems under cover). Overall, the key point of note for investors is that this commitment from Newmont is a strong validation of the potential exploration upside in Ernest Giles. Typically, global major of this size would be unlikely to be involved in a project unless they saw potential for a large scale resource. News flow from Newmont’s results will be key to Greatland Gold shares over this 6 month period.
23 Jun 17
Genedrive -Ready to launch the first point-of-care HepC test
genedrive, an emerging UK medtech company, focuses on the development and commercialization of an innovative, point-of-care diagnostic system, also called Genedrive® (in this report, "genedrive" refers to the company, whereas "Genedrive®" indicates the product). genedrive is poised to become the first company to launch a decentralized Hepatitis C diagnostic, entering a large market at a time when new curative therapies for the disease are transforming opportunities for testing and treatment. A Genedrive® TB diagnostic has already been launched and the platform has a wide range of alternative applications.
15 Jun 17
Capital Network Research and Daily Commentaries
Research Tree offers Capital Network research, providing ongoing coverage of 45 shares. We offer 55 reports from Capital Network on Research Tree.
Research reports provided by Capital Network
Companies covered by Capital Network
Sectors covered by Capital Network